Nirmal Drugs Pvt Ltd - Company Profile

It is a financial services private limited company based in Kolkata, West Bengal, India, established in 1984.
1984 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Nirmal Drugs Pvt Ltd

Nirmal Drugs Pvt Ltd, a active private limited company, was established on 21 June 1984 in Kolkata, West Bengal, India. Engaging in real estate financing within the trade sector, it holds CIN: U85195WB1984PTC037620. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.55 M.

It upholds a compliant status. Its leadership includes Anand Kumar Luharuka (Director), Madhu Luharuka (Director). Past directors included Rajesh Goenka, Ashok Bhat, Narayan Kumar Loharuka. It holds ₹7.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 4 Canal West Road, Kolkata, West Bengal, 700015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85195WB1984PTC037620

  • Registration Number

    037620

  • Incorporation Date

    21 June 1984

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹0.55 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 0.55 M
  • Company Age 41 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.00 M
  • Revenue Growth **** -2.57%
  • Profit Growth **** 127.88%
  • Ebitda **** 107.23%
  • Net Worth 0.63%
  • Total Assets **** 0.36%
Company report

Nirmal Drugs Pvt Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nirmal Drugs Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nirmal Drugs Pvt Ltd?
Current Directors
Name Designation Appointment Date Status
Anand Kumar Luharuka Director 03 Sep 2008 Current
Madhu Luharuka Director 01 Mar 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 09 Jan 2009 Past
Pramod Abcsdd Director 09 Jan 2009 Past
Pramod Abcsdd Director 01 Mar 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nirmal Drugs.

Nirmal Drugs Pvt Ltd, for the financial year ended 2019, experienced Minor drop in revenue, with a 2.57% decrease. The company also saw a substantial improvement in profitability, with a 127.88% increase in profit. The company's net worth moved up by a moderate rise of 0.63%.

Nirmal Drugs revenue growth over time
Nirmal Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -2.57%
*******
*******
*******
*******
Revenue from Operations
*******
 -2.57%
*******
*******
*******
*******
Total Assets
*******
 0.36%
*******
*******
*******
*******
Profit or Loss
*******
 127.88%
*******
*******
*******
*******
Net Worth
*******
 0.63%
*******
*******
*******
*******
EBITDA
*******
 107.23%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nirmal Drugs?

In 2019, Nirmal Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹7,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 0.70 Cr
Latest Charge Details
Date Lender Amount Status
10 Jul 1989 Canara Bank ₹2.50 M Open
22 Nov 1988 Canara Bank ₹2.50 M Open
01 Jan 1986 Canara Bank ₹1.00 M Open
19 Dec 1985 Canara Bank ₹1.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Nirmal Drugs?

Unlock and access historical data on people associated with Nirmal Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nirmal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirmal Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nirmal Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Nirmal Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Nirmal Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was completed.

  • Director Appointment

    The activity Madhu Luharuka was appointed as a Director was appointed as a Director on 01 Mar 2017 & has been associated with this company since 9 years 2 days . was completed.

  • Director Appointment

    The activity Anand Kumar Luharuka was appointed as a Director was appointed as a Director on 03 Sep 2008 & has been associated with this company since 17 years 6 months . was completed.

  • Charges

    A charge with Canara Bank amounted to Rs. 2.50 M with Charge ID 90246797 was registered on 10 Jul 1989. was recorded as a recent event.

  • Charges

    The activity A charge with Canara Bank of Rs. 2.50 M registered on 22 Nov 1988 with Charge ID 90246794 was modified on 10 Jul 1989. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nirmal Drugs Pvt Ltd?

The CIN of Nirmal Drugs Pvt Ltd is U85195WB1984PTC037620.

Where is Nirmal Drugs Pvt Ltd headquartered?

Nirmal Drugs Pvt Ltd is headquartered at 4 Canal West Road, Kolkata, West Bengal, 700015.

When was Nirmal Drugs Pvt Ltd incorporated?

Nirmal Drugs Pvt Ltd was incorporated on 21 June 1984.

Who are the current directors of Nirmal Drugs Pvt Ltd?

The current directors of Nirmal Drugs Pvt Ltd are

What is the primary industry of Nirmal Drugs Pvt Ltd?

The primary industry of Nirmal Drugs Pvt Ltd is Trade.

Is Nirmal Drugs Pvt Ltd a listed company?

Nirmal Drugs Pvt Ltd is unlisted.

What is the capital structure of Nirmal Drugs Pvt Ltd?

The authorized capital of Nirmal Drugs Pvt Ltd is ₹2.50 M, and the paid-up capital is ₹0.55 M.

What is the compliance status of Nirmal Drugs Pvt Ltd?

The compliance status of Nirmal Drugs Pvt Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available